Skip to main content
Log in

Malignant hyperthermia syndrome—Evidence for denervation changes in human skeletal muscle

Syndrom der Malignen Hyperthermie: Hinweise auf Denervationsveränderungen im menschlichen Skeletmuskel

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Bei Personen, welche zur malignen Hyperthermii disponiert sind, legen denervationsähnliche Veränderungen und abnorme Mitochondrien eine neuropathische Basis des Syndroms nahe. Möglicherweise stellt ein Defekt in der mitochondrialen ATP-Synthese, der auf einer Denervation beruht und durch einige Anaesthetika potenzient wird, die primäre Lasion der Muskelfaser beim Syndrom der malignen Hyperthermie Menschen dar.

Summary

The presence of denervation-like changes and abnormal mitochondria in the muscle of carriers of the malignant hyperthermia syndrome suggest a neuropathic basis for the human syndrome. A defect in mitochondrial ATP synthesis resulting from denervation, and potentiated by some general anaesthetics, may be the primary muscle fibre lesion in the human malignant hyperthermic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Britt, B.A., Kalow, W.: Malignant hyperthermia: A statistical review. Canad. Anaesth. Soc. J.17, 293–315 (1970)

    PubMed  Google Scholar 

  2. Isaacs, H., Barlow, M.B.: The genetic background to malignant hyperpyrexia revealed by serum creatine phosphokinase estimations in asymptomatic relatives. Brit. J. Anaesth.42, 1077–1084 (1970)

    PubMed  Google Scholar 

  3. Isaacs, H., Barlow, M.B.: Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy. Brit. med. J.1, 275–277 (1970)

    Google Scholar 

  4. Britt, B.A., Kalow, W., Gordon, A., Humphrey, J.G., Rewcastle, N.B.: Malignant hyperthermia: an investigation of five patients. Canad. Anaesth. Soc. J.20, 431–467 (1973)

    PubMed  Google Scholar 

  5. Isaacs, H., Heffron, J.J.A.: Morphological and biochemical defects in muscle of human carriers of the malignant hyperthermia syndrome. Brit. J. Anaesth.47, 475–481 (1975)

    PubMed  Google Scholar 

  6. Berman, M.C., Kench, J.E.: Biochemical features of malignant hyperthermia. In: International Symposium on Malignant Hyperthermia (Eds. Gordon, R.A., Britt, B.A., Kalow, W.), pp. 287. Springfield, Illinois: C.C. Thomas 1973

    Google Scholar 

  7. Heffron, J.J.A., Mitchell, G.: Procaine for malignant hyperthermia. New Engl. J. Med.292, 266–267 (1975)

    Google Scholar 

  8. Ellis, F.R., Harriman, D.G.F., Keaney, N.P., Kejei-Mensah, K., Tyrell, J.H.: Halothane-induced muscle contracture as a cause of hyperpyrexia. Brit. J. Anaesth.43, 721–722 (1971)

    PubMed  Google Scholar 

  9. Margreth, A., Salviati, G., Carroro, V.: Neural control of the activity of the calcium-transport-system in sarcoplasmic reticulum of rat skeletal muscle. Nature (Lond.)241, 285–286 (1973)

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heffron, J.J.A., Isaacs, H. Malignant hyperthermia syndrome—Evidence for denervation changes in human skeletal muscle. Klin Wochenschr 54, 865–867 (1976). https://doi.org/10.1007/BF01483587

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01483587

Schlüsselwörter

Key words

Navigation